CRESCENT BIOPHARMA INC. CBIO
COM · Common Stock · CUSIP G2545C104
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersWaltham, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $11.85.
Trends to Q4 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2025 | 31 |
| Q3 2025 | 41 |
| Q4 2025 | 56 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2025 | 22 | 13 |
| Q4 2025 | 37 | 15 |
Biggest buyers
| FMR LLC | Added | +2.7m |
| FCPM III SERVICES B.V. | New | +1.7m |
| Vestal Point Capital, LP | New | +1.5m |
| BVF INC/IL | Added | +1.4m |
| Fairmount Funds Management LLC | Added | +1.4m |
| Opaleye Management Inc. | New | +1.2m |
| Venrock Adviser, LLC | Added | +745.7k |
| ADAR1 Capital Management, LLC | New | +606.0k |
| RTW INVESTMENTS, LP | New | +372.9k |
| Point72 Asset Management, L.P. | New | +300.0k |
Biggest sellers
| Commodore Capital LP | Sold out | -450.8k |
| Frazier Life Sciences Management, L.P. | Sold out | -273.0k |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Sold out | -200.0k |
| Soleus Capital Management, L.P. | Sold out | -200.0k |
| VANGUARD GROUP INC | Reduced | -100.4k |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | -45.5k |
| Jefferies Financial Group Inc. | Reduced | -38.5k |
| CITADEL ADVISORS LLC | Sold out | -25.6k |
| MARSHALL WACE, LLP | Reduced | -21.9k |
| Affinity Asset Advisors, LLC | Sold out | -18.0k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Fairmount Funds Management LLC
13D · may seek influence
-2.0 pts · filed 2026-07-20
Stated purposeItem 4 of the Statement is hereby amended and supplemented as follows: Fund II purchased the Ordinary Shares and Pre-funded Warrants referenced in Item 3 for investment purposes. Lock-Up Agreement In connection with the Company's underwritten public offering of Ordinary Shares and Pre-Funded Warrants that closed on July 16, 2026, the Reporting Persons entered into a customary lock-up letter agreement (the "Lock-Up Agreement") with Jefferies LLC and TD Securities (USA) LLC acting as the Representatives (collectively, the "Representatives") of the underwiters party to to an underwriting agreement with the Company. Pursuant to the Lock-Up Agreement, the Reporting Persons agreed to refrain from selling shares of the Company's securities without the consent of the Representatives, and other… Full filing |
16.5% |
| FMR LLC 13G · institution filed 2026-02-05 | 15.0% |
| BIOTECHNOLOGY VALUE FUND L P 13G · passive investor filed 2025-08-14 | 10.0% |
| Venrock Healthcare Capital Partners III, L.P. 13G · passive investor filed 2026-02-17 | 9.5% |
| ForGrowth III PA B.V. 13G · passive investor new · filed 2025-12-11 | 6.1% |
| BlackRock, Inc. 13G · institution new · filed 2026-10-27 | 5.6% |
| Vestal Point Capital, LP 13G · institution new · filed 2026-02-17 | 5.4% |
Fell to 5% or below in the last year: TANG CAPITAL MANAGEMENT LLC (4.2%, 2026-05-15)
Insider purchases and sales in Q4 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 2 | $82.9k | 0 | — | — |
| Q3 2024 | 0 | — | 0 | — | — |
| Q4 2024 | 0 | — | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
| Q3 2025 | 0 | — | 0 | — | — |
| Q4 2025 | 1 | $18.2m | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-12-04 | Harwin Peter Evan +3 Director · By Fairmount Healthcare Fund II L.P. | Bought | $18.2m1.4m shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q4 2025
| Manager | Shares | Change |
|---|---|---|
| FMR LLC 0.00% of their portfolio | 4.1m $49.0m | Added +2.7m |
| BVF INC/IL 1.10% of their portfolio | 2.7m $32.6m | Added +1.4m |
| Fairmount Funds Management LLC 2.48% of their portfolio | 2.7m $32.6m | Added +1.4m |
| Venrock Adviser, LLC 1.25% of their portfolio | 2.1m $25.3m | Added +745.7k |
| FCPM III SERVICES B.V. 2.61% of their portfolio | 1.7m $19.9m | New |
| Vestal Point Capital, LP 0.65% of their portfolio | 1.5m $17.8m | New |
| Opaleye Management Inc. 1.84% of their portfolio | 1.2m $14.0m | New |
| TANG CAPITAL MANAGEMENT LLC 0.51% of their portfolio | 872.4k $10.3m | Added +192.6k |
| ADAR1 Capital Management, LLC 0.54% of their portfolio | 606.0k $7.2m | New |
| Logos Global Management LP 0.47% of their portfolio | 600.0k $7.1m | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 557.5k $6.6m | Reduced -100.4k |
| PERCEPTIVE ADVISORS LLC 0.10% of their portfolio | 453.7k $5.4m | Unchanged |
| Deep Track Capital, LP 0.12% of their portfolio | 453.7k $5.4m | Unchanged |
| Boxer Capital Management, LLC 1.18% of their portfolio | 453.7k $5.4m | Unchanged |
| RTW INVESTMENTS, LP 0.04% of their portfolio | 372.9k $4.4m | New |
| NEXTBio Capital Management LP 2.59% of their portfolio | 372.9k $4.4m | First filing |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 338.1k $4.0m | Reduced -45.5k |
| Driehaus Capital Management LLC 0.02% of their portfolio | 302.5k $3.6m | Unchanged |
| Point72 Asset Management, L.P. 0.01% of their portfolio | 300.0k $3.6m | New |
| HEIGHTS CAPITAL MANAGEMENT, INC 1.18% of their portfolio | 264.0k $3.1m | New |
| Alyeska Investment Group, L.P. 0.01% of their portfolio | 264.0k $3.1m | New |
| WELLINGTON MANAGEMENT GROUP LLP 0.00% of their portfolio | 143.4k $1.6m | Added +125.7k |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 125.2k $1.5m | Added +96.9k |
| Balyasny Asset Management L.P. 0.00% of their portfolio | 111.7k $1.3m | New |
| BlackRock, Inc. 0.00% of their portfolio | 109.2k $1.3m | Added +115 |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 91.1k $1.1m | Added +21.9k |
| Stonepine Capital Management, LLC 0.82% of their portfolio | 87.7k $1.0m | New |
| Blackstone Inc. 0.00% of their portfolio | 75.6k $896.8k | Unchanged |
| Woodline Partners LP 0.00% of their portfolio | 74.0k $877.6k | New |
| Burkehill Global Management, LP 0.06% of their portfolio | 74.0k $844.3k | New |
| Jefferies Financial Group Inc. 0.01% of their portfolio | 64.2k $761.9k | Reduced -38.5k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 61.9k $733.9k | New |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 57.0k $676.6k | New |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 46.7k $553.9k | Added +19.8k |
| TWO SIGMA ADVISERS, LP 0.00% of their portfolio | 32.5k $385.4k | New |
| MORGAN STANLEY 0.00% of their portfolio | 27.5k $326.4k | Added +27.4k |
| STATE STREET CORP 0.00% of their portfolio | 26.2k $310.9k | Added +7.6k |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 25.2k $299.4k | Reduced -11.7k |
| MOORE CAPITAL MANAGEMENT, LP 0.01% of their portfolio | 25.0k $296.5k | New |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.00% of their portfolio | 24.9k $288.9k | Reduced -20 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 23.3k $276.8k | Added +23.3k |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 23.0k $272.4k | New |
| MARSHALL WACE, LLP 0.00% of their portfolio | 21.8k $258.9k | Reduced -21.9k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 17.2k $204.3k | Added +413 |
| HRT FINANCIAL LP 0.00% of their portfolio | 13.1k $155.0k | New |
| OMERS ADMINISTRATION Corp 0.00% of their portfolio | 11.6k $137.6k | New |
| UBS Group AG 0.00% of their portfolio | 7.1k $84.5k | Reduced -5.5k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 5.6k $66.1k | Added +1.7k |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 3.6k $42.5k | Added +3.6k |
| CITIGROUP INC 0.00% of their portfolio | 623 $7.4k | Reduced -175 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 409 $4.9k | Added +209 |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 68 $806 | Unchanged |
| Avion Wealth 0.00% of their portfolio | 40 $0 | New |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 26 $308 | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 20 $0 | Unchanged |
| GROUP ONE TRADING LLC 0.00% of their portfolio | 4 $47 | Reduced -78 |